Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0000899243-20-025165

Options or other derivatives

  • Director acquired 1,167.21 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
McBride John S. Director 2020-09-11 Grant or award · Stock Option (Right to Buy) +1,167.21 1,167.21 D: show line 1 in the form
Loading xslF345X03/doc4.xml…